Published in Radiographics on November 01, 2010
MDCT evaluation of potential living renal donor, prior to laparoscopic donor nephrectomy: What the transplant surgeon wants to know? Indian J Radiol Imaging (2014) 1.17
Angio CT assessment of anatomical variants in renal vasculature: its importance in the living donor. Insights Imaging (2013) 0.95
Accessory renal arteries in a Caribbean population: a computed tomography based study. Springerplus (2013) 0.79
Revisiting renovascular imaging for renal sympathetic denervation: current techniques and applications. Eur Radiol (2014) 0.77
Anatomic variations of the renal arteries, as characterized by computed tomography angiography: rule or exception? Its usefulness in surgical plannning. Radiol Bras (2016) 0.75
Assessment of Potential Live Kidney Donors and Computed Tomographic Renal Angiograms at Christchurch Hospital. Adv Urol (2016) 0.75
MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol (2011) 3.57
TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol (2012) 2.24
Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res (2010) 2.23
Laparoscopic living-donor nephrectomy: analysis of the existing literature. Eur Urol (2010) 2.07
Air cystoscopy is superior to water cystoscopy for the diagnosis of active hematuria. J Urol (2013) 2.06
Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol (2008) 2.04
DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers. J Urol (2009) 1.59
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment. BJU Int (2012) 1.58
Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy. Eur Urol (2007) 1.55
Validation of Randall's plaque theory using unenhanced abdominal computed tomography. Urology (2013) 1.55
Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. BJU Int (2014) 1.49
The influence of family history on prostate cancer risk: implications for clinical management. BJU Int (2010) 1.48
Orthotopic kidney transplantation: an alternative surgical technique in selected patients. Eur Urol (2010) 1.45
Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer? BJU Int (2014) 1.44
Recent advances of natural orifice transluminal endoscopic surgery in urological surgery. Int J Urol (2013) 1.39
Lymphadenectomy in the surgical management of penile cancer. Eur Urol (2009) 1.19
Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum (2008) 1.18
Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol (2006) 1.14
MR imaging of temporomandibular joint dysfunction: a pictorial review. Radiographics (2006) 1.07
Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer. Mol Cancer Ther (2014) 1.07
Feasibility of transvaginal natural orifice transluminal endoscopic surgery-assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future? Eur Urol (2011) 1.05
Multiplex protein signature for the detection of bladder cancer in voided urine samples. J Urol (2013) 1.01
Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Int J Cancer (2013) 1.00
Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol (2008) 0.99
Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. Virology (2012) 0.99
Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients. Transpl Int (2008) 0.97
Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK. BJU Int (2010) 0.97
Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction. BJU Int (2005) 0.97
Significance of and contributing factors for a high resistive index on Doppler sonography of the hepatic artery immediately after surgery: prognostic implications for liver transplant recipients. AJR Am J Roentgenol (2003) 0.95
Insights on the permeability of wide protein channels: measurement and interpretation of ion selectivity. Integr Biol (Camb) (2010) 0.95
Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles in bladder cancer. Eur Urol (2006) 0.94
Sonography of Budd-Chiari syndrome. AJR Am J Roentgenol (2006) 0.94
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. BJU Int (2008) 0.94
Malignant melanoma with metastasis into the capitate. Eur J Radiol (2005) 0.94
Dielectric saturation of water in a membrane protein channel. Phys Chem Chem Phys (2008) 0.93
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy? World J Urol (2014) 0.92
Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol (2005) 0.92
Electrostatic properties and macroscopic electrodiffusion in OmpF porin and mutants. Bioelectrochemistry (2007) 0.91
Atypical subcutaneous emphysema mimicking cellulitis. Arch Dermatol (2011) 0.90
Sonography of the caudate vein: value in diagnosing Budd-Chiari syndrome. AJR Am J Roentgenol (2003) 0.90
Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet (2007) 0.89
Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms. J Urol (2006) 0.88
Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily. Urology (2005) 0.87
Value of Doppler sonography for predicting clinical outcome after renal artery revascularization in atherosclerotic renal artery stenosis. J Ultrasound Med (2005) 0.87
Diagnostic imaging: magnetic resonance imaging, computed tomography, and ultrasound. Semin Ultrasound CT MR (2007) 0.86
Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge. Biochim Biophys Acta (2013) 0.86
Pathways of lymphatic spread in male urogenital pelvic malignancies. Radiographics (2011) 0.86
Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer. Urology (2011) 0.86
Abdominal computed tomography--a new tool for predicting recurrent stone disease. J Endourol (2013) 0.86
Ligasure versus sutures in bladder replacement with Montie ileal neobladder after radical cystectomy. Arch Ital Urol Androl (2003) 0.85
A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits. Prostate (2009) 0.85
Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction. Transplantation (2009) 0.85
Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia. BJU Int (2012) 0.85
Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays. BMC Res Notes (2008) 0.85
The evolution of CT diagnosed papillae tip microcalcifications: can we predict the development of stones? J Endourol (2014) 0.84
Overcharging below the nanoscale: multivalent cations reverse the ion selectivity of a biological channel. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.84
Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis. J Hepatol (2010) 0.84
Utility of multidetector CT in severe postpartum hemorrhage. Radiographics (2012) 0.84
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations. Mol Cancer (2014) 0.83
Diagnosis of bladder cancer: contrast-enhanced ultrasound. Abdom Imaging (2009) 0.83
Sonography of a mercury foreign body in the hand. J Ultrasound Med (2004) 0.83
Molecular characterization of upper urinary tract tumours. BJU Int (2009) 0.83
Hydrophobic pulmonary surfactant proteins SP-B and SP-C induce pore formation in planar lipid membranes: evidence for proteolipid pores. Biophys J (2013) 0.83
Evaluation of abdominal aortic aneurysm after endovascular repair: prospective validation of contrast-enhanced US with a second-generation US contrast agent. Radiology (2012) 0.83
Transvaginal NOTES-assisted laparoscopic nephrectomy: a survival study in a sheep model. Surg Endosc (2011) 0.81
Unenhanced CT findings can predict the development of urinary calculi in stone-free patients. Eur Radiol (2012) 0.81
Castration-resistant metastatic prostate cancer: current status and treatment possibilities. Clin Transl Oncol (2012) 0.81
Prospective evaluation of CT indeterminate renal masses using US and contrast-enhanced ultrasound. Abdom Imaging (2015) 0.81
Prognostic value of IL-6 in localized prostatic cancer. Anticancer Res (2010) 0.81
Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation. Transplantation (2003) 0.81
Membrane potential bistability in nonexcitable cells as described by inward and outward voltage-gated ion channels. J Phys Chem B (2014) 0.81
Long-term mycophenolate monotherapy in human leukocyte antigen (HLA)-identical living-donor kidney transplantation. Transplant Res (2014) 0.81
Iatrogenic carotid-jugular arteriovenous fistula: color Doppler sonographic findings and treatment with covered stent. J Clin Ultrasound (2006) 0.81
Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement? BJU Int (2012) 0.80
Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice. BJU Int (2006) 0.80
Nanobiotechnology: A fluid approach to simple circuits. Nat Nanotechnol (2009) 0.79
Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med (2013) 0.79
Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer. BMC Cancer (2014) 0.79
Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. J Clin Ultrasound (2003) 0.79
Second to fourth digit ratio, adult testosterone level and testosterone deficiency. BJU Int (2011) 0.79
Adhesion molecules expression as a potential marker of prostate cancer aggressivity. A TMA study of radical prostatectomy specimens. Arch Ital Urol Androl (2006) 0.79
Higher second fourth digit ratio predicts higher incidence of prostate cancer in prostate biopsy. Arch Esp Urol (2012) 0.79
Pathways of lymphatic spread in gynecologic malignancies. Radiographics (2015) 0.79